Cargando…

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

Unleashing adaptive immunity via immune checkpoint inhibitors (ICPIs) in many cancer types led to durable antitumor responses and prolonged survivals and also added some new immune-related adverse events (irAEs) to the ‘old-fashioned’ safety profile of chemotherapy. Among bowel and endocrine irAEs,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziogas, Dimitrios C, Gkoufa, Aikaterini, Cholongitas, Evangelos, Diamantopoulos, Panagiotis, Anastasopoulou, Amalia, Ascierto, Paolo Antonio, Gogas, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607607/ https://www.ncbi.nlm.nih.gov/pubmed/33144335 http://dx.doi.org/10.1136/jitc-2020-001322

Ejemplares similares

Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
por: Ziogas, Dimitrios C, et al.
Publicado: (2020)

Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report
por: Anastasopoulou, Amalia, et al.
Publicado: (2022)

Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2020)

The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature
por: Anastasopoulou, Amalia, et al.
Publicado: (2021)

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2022)

Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
por: Anastasopoulou, Amalia, et al.
Publicado: (2023)

Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature
por: Diamantopoulos, Panagiotis T, et al.
Publicado: (2023)

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
por: Gauci, Marie-Léa, et al.
Publicado: (2021)

A case report of immune-mediated arthritis in a patient with cutaneous melanoma receiving checkpoint inhibition therapy
por: Papaxoinis, George, et al.
Publicado: (2020)

Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations
por: Anastasopoulou, Amalia, et al.
Publicado: (2019)

Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers
por: Ziogas, Dimitrios C., et al.
Publicado: (2022)

An Unusual Presentation of Diffuse Large B-Cell Lymphoma
por: Gkoufa, Aikaterini, et al.
Publicado: (2022)

Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic Review
por: Ziogas, Dimitrios C., et al.
Publicado: (2021)

COVID‑19 vaccination in liver transplant recipients (Review)
por: Gkoufa, Aikaterini, et al.
Publicado: (2023)

When Is Enough, Enough?
por: Ng, Perryn, et al.
Publicado: (2020)

Acute Lymphoblastic Leukemia and Invasive Mold Infections: A Challenging Field
por: Stafylidis, Christos, et al.
Publicado: (2022)

Extending the conversation over the immune-related hepatotoxicity: author response to Dr. Gauci et al
por: Ziogas, Dimitrios C, et al.
Publicado: (2021)

An overview of antibody–drug conjugates in oncological practice
por: Theocharopoulos, Charalampos, et al.
Publicado: (2020)

Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma
por: Kassi, Eva, et al.
Publicado: (2019)

Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond
por: Theocharopoulos, Charalampos, et al.
Publicado: (2021)

Mechanistic and Epidemiologic Data: When Is Enough Enough?
por: Roberts, R
Publicado: (2002)

NETosis in Wound Healing: When Enough Is Enough
por: Sabbatini, Maurizio, et al.
Publicado: (2021)

When landmarks are not enough
por: Hill, Paul F
Publicado: (2023)

Bacillus Cereus in Hematological Malignancies
por: Markouli, Mariam, et al.
Publicado: (2022)

When There Is Not Enough Evidence and When Evidence Is Not Enough: An Australian Indigenous Smoking Policy Study
por: Vujcich, Daniel, et al.
Publicado: (2016)

What is changing in the adjuvant treatment of melanoma?
por: Ascierto, Paolo A., et al.
Publicado: (2017)

Contact tracing to control infectious disease: when enough is enough
por: Armbruster, Benjamin, et al.
Publicado: (2007)

Real-time linkage: when is near enough good enough?
por: Irvine, Katrina, et al.
Publicado: (2017)

When one cell is enough
por: Ceredig, Rhodri
Publicado: (2012)

When non-coding is not enough
por: Anfossi, Simone, et al.
Publicado: (2020)

When rotational atherectomy is not enough
por: Atefi, Negar, et al.
Publicado: (2021)

Postoperative abdominal free air: How much and when is enough? Report of two cases
por: Melemeni, Aikaterini, et al.
Publicado: (2021)

When enough data are not enough to enact policy: The failure to ban chlorpyrifos
por: Trasande, Leonardo
Publicado: (2017)

Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas
por: MANTA, ASPASIA, et al.
Publicado: (2023)

Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment
por: Ziogas, Dimitrios C., et al.
Publicado: (2023)

SUN-182 When Insulin Is Not Enough...
por: DiCenso, Daniela, et al.
Publicado: (2019)

When an embarrassment of riches isn’t enough
por: Patel, Krina, et al.
Publicado: (2022)

Multichamber Involvement of Metastatic Cardiac Melanoma
por: Bonou, Maria S., et al.
Publicado: (2022)

Perioperative Fluid Resuscitation in Free Flap Breast Reconstruction: When Is Enough Enough?
por: Karamanos, Efstathios, et al.
Publicado: (2020)

Surprise, surprise: STAT5 is not enough to stop the steroids
por: Fernandes, Marta B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3r6ab6dpbb8lfesabkkems36r